Spring Bank Pharmaceuticals’ Definitive Share Exchange Agreement With F-star Therapeutics

Ambrogio Visconti

Lowenstein Sandler LLP advised Spring Bank Pharmaceuticals, Inc. on the deal. Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now